CVE:NDVA - Indiva Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$0.74 -0.01 (-1.33 %)
(As of 05/24/2018 03:21 PM ET)
Previous CloseC$0.75
Today's RangeC$0.74 - C$0.78
52-Week RangeC$0.64 - C$3.00
Volume22,451 shs
Average Volume362,488 shs
Market CapitalizationC$51.87 million
P/E RatioN/A
Dividend YieldN/A
Beta0.56

About Indiva (CVE:NDVA)

Indiva Limited engages in the production of medical grade cannabis products in Canada. It offers dried cannabis flowers, and medical cannabis oils and extracts; and sativas, indicas, hybrids, and high-CBD strains. The company is based in Ottawa, Canada.

Receive NDVA News and Ratings via Email

Sign-up to receive the latest news and ratings for NDVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
SymbolCVE:NDVA
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares1,333,000

Indiva (CVE:NDVA) Frequently Asked Questions

What is Indiva's stock symbol?

Indiva trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NDVA."

Who are some of Indiva's key competitors?

Who are Indiva's key executives?

Indiva's management team includes the folowing people:
  • Mr. Niel Marotta, Founder, Pres, CEO & Director
  • Mr. Koby Smutylo, Founder, COO, Chief of Legal, Chief of Bus. Devel., Corp. Sec. & Director
  • Ms. Jennifer Welsh, Chief Financial Officer
  • Mr. John McCluskey, VP of Quality Assurance & Regulatory Affairs

Has Indiva been receiving favorable news coverage?

News articles about NDVA stock have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Indiva earned a media sentiment score of 0.04 on Accern's scale. They also assigned media headlines about the company an impact score of 45.89 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of Indiva?

Shares of NDVA and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Indiva's stock price today?

One share of NDVA stock can currently be purchased for approximately C$0.74.

How big of a company is Indiva?

Indiva has a market capitalization of C$51.87 million.


MarketBeat Community Rating for Indiva (NDVA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  8 (Vote Outperform)
Underperform Votes:  9 (Vote Underperform)
Total Votes:  17
MarketBeat's community ratings are surveys of what our community members think about Indiva and other stocks. Vote "Outperform" if you believe NDVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NDVA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Indiva (CVE:NDVA) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/24/2016 forward)

Earnings

Dividends

Indiva (CVE:NDVA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Indiva (CVE NDVA) Insider Trading and Institutional Ownership History

Insider Trading History for Indiva (CVE:NDVA)

Indiva (CVE NDVA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/29/2018John A MarottaDirectorBuy10,000C$1.15C$11,500.00
1/24/2018Olivier Robert Fran BenloulouInsiderSell152,900C$1.20C$183,480.00
1/22/2018Olivier Robert Fran BenloulouInsiderSell81,300C$1.22C$99,186.00
1/17/2018Olivier Robert Fran BenloulouInsiderSell25,000C$1.25C$31,250.00
(Data available from 1/1/2013 forward)

Headlines

Indiva (CVE NDVA) News Headlines

Source:
DateHeadline
INDIVA Announces Inclusion in Horizons Emerging Marijuana Growers Index ETF - GlobeNewswire (press release)INDIVA Announces Inclusion in Horizons Emerging Marijuana Growers Index ETF - GlobeNewswire (press release)
globenewswire.com - February 16 at 3:40 PM
Indiva Limited (NDVA) Director Acquires C$11,500.00 in StockIndiva Limited (NDVA) Director Acquires C$11,500.00 in Stock
www.americanbankingnews.com - January 29 at 6:50 PM
Olivier Robert Fran Benloulou Sells 152,900 Shares of Indiva Limited (NDVA) StockOlivier Robert Fran Benloulou Sells 152,900 Shares of Indiva Limited (NDVA) Stock
www.americanbankingnews.com - January 24 at 9:24 PM
IIROC Trading Halt - NDVAIIROC Trading Halt - NDVA
www.bizjournals.com - January 24 at 8:40 AM
Olivier Robert Fran Benloulou Sells 81,300 Shares of Indiva Limited (NDVA) StockOlivier Robert Fran Benloulou Sells 81,300 Shares of Indiva Limited (NDVA) Stock
www.americanbankingnews.com - January 23 at 12:22 AM
Olivier Robert Fran Benloulou Sells 25,000 Shares of Indiva Limited (NDVA) StockOlivier Robert Fran Benloulou Sells 25,000 Shares of Indiva Limited (NDVA) Stock
www.americanbankingnews.com - January 19 at 4:26 PM

SEC Filings

Indiva (CVE:NDVA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Indiva (CVE NDVA) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.